ABAbay Burusie

Abay Burusie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abay Burusie has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Fikre Enquesilassie

    School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia

    5 shared publications
  • Adamu Addissie

    School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia

    3 shared publications
  • Nicole Salazar-Austin

    Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    3 shared publications
  • Adamu Addissie

    Department of Preventive Medicine, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia

    2 shared publications
  • Berhe Dessalegn

    Affiliation Department of Public Health, College of Health Sciences, Adigrat University, Adigrat, Ethiopia

    1 shared publication
  • Tafesse Lamaro

    Affiliation Department of Nursing, College of Health Sciences, Mizan-Tepi University, Tepi, Ethiopia

    1 shared publication

Latest Publications

  • Open Access

    Determinants of tuberculosis disease development in children in central Ethiopia: A matched case-control study

    by Abay Burusie, Fikre Enquesilassie, Nicole Salazar-Austin, Adamu Addissie

    The risk factors for tuberculosis (TB) disease development in children remained understudied, particularly in low-income countries like Ethiopia. The objective of this study was to identify determinants of TB disease development in general and in relation to BCG vaccination in children in central Ethiopia. We employed a 1:1 age-matched case-control design to compare the characteristics of children who developed TB (cases) with those who did not (controls). Data were collected in healthcare facilities in Addis Ababa city, Adama, and Bishoftu towns between September 25, 2021, and June 24, 2022. Two hundred and fifty-six cases were drawn at random from a list of childhood TB patients entered into SPSS software, and 256 controls were selected sequentially at triage from the same healthcare facilities where the cases were treated. A bivariate conditional logistic regression analysis was performed first to select candidate variables with p-values less than or equal to 0.20 for the multivariable model. Finally, variables with a p-value less than 0.05 for a matched adjusted odds ratio (mORadj) were reported as independent determinants of TB disease development. The mean age of the cases was nine years, while that of the controls was 10 years. Males comprised 126 cases (49.2%) and 119 controls (46.5%), with the remainder being females. Ninety-nine (38.7%) of the cases were not BCG-vaccinated, compared to 58 (22.7%) of the controls. Household TB contact was experienced by 43 (16.8%) of the cases and 10 (3.9%) of the controls. Twenty-two (8.6%) of the cases and six (2.3%) of the controls were exposed to a cigarette smoker in their household. Twenty-two (8.6%) of the cases and three (1.2%) of the controls were positive for HIV. Children who were not vaccinated with BCG at birth or within two weeks of birth had more than twice the odds (mORadj = 2.11, 95% CI = 1.28–3.48) of developing TB compared to those who were. Children who ever lived with a TB-sick family member (mORadj = 4.28, 95% CI = 1.95–9.39), smoking family members (mORadj = 3.15, 95% CI = 1.07–9.27), and HIV-infected children (mORadj = 8.71, 95% CI = 1.96–38.66) also had higher odds of developing TB disease than their counterparts. Being BCG-unvaccinated, having household TB contact, having a smoker in the household, and being HIV-infected were found to be independent determinants of TB disease development among children.


  • Open Access

    Epidemiology of childhood tuberculosis and predictors of death among children on tuberculosis treatment in central Ethiopia: an extended Cox model challenged survival analysis

    by Abay Burusie, Fikre Enquesilassie, Nicole Salazar-Austin, Adamu Addissie

    Background: Childhood tuberculosis (TB) was poorly studied in Ethiopia. This study aimed to describe the epidemiology of childhood TB and identify predictors of death among children on TB treatment. Methods: This is a retrospective cohort study of children aged 16 and younger who were treated for TB between 2014 and 2022. Data were extracted from TB registers of 32 healthcare facilities in central Ethiopia. Phone interview was also conducted to measure variables without a space and not recorded in the registers. Frequency tables and a graph were used to describe the epidemiology of childhood TB. To perform survival analysis, we used a Cox proportional hazards model, which was then challenged with an extended Cox model. Results: We enrolled 640 children with TB, 80 (12.5%) of whom were under the age of two. Five hundred and fifty-seven (87.0%) of the enrolled children had not had known household TB contact. Thirty-six (5.6%) children died while being treated for TB. Nine (25%) of those who died were under the age of two. HIV infection (aHR = 4.2; 95% CI = 1.9–9.3), under nutrition (aHR = 4.2; 95% CI = 2.2-10.48), being under 10 years old (aHR = 4.1; 95% CI = 1.7–9.7), and relapsed TB (aHR = 3.7; 95% CI = 1.1–13.1) were all independent predictors of death. Children who were found to be still undernourished two months after starting TB treatment also had a higher risk of death (aHR = 5.64, 95% CI = 2.42–13.14) than normally nourished children. Conclusions: The majority of children had no known pulmonary TB household contact implying that they contracted TB from the community. The death rate among children on TB treatment was unacceptably high, with children under the age of two being disproportionately impacted. HIV infection, baseline as well as persistent under nutrition, age < 10 years, and relapsed TB all increased the risk of death in children undergoing TB treatment.


  • Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis

    by Abay Burusie, Fikre Enquesilassie, Adamu Addissie

    Introduction: Numerous studies have explored the effect of cigarette smoking on tuberculosis treatment outcomes but with dissimilar conclusions. Objective: To determine the effect of cigarette smoking on tuberculosis treatment outcomes. Methods: PubMed, Cochrane library, and Google scholar databases were searched last on February 27, 2019. We applied the random-effects model for the analysis. Publication bias was assessed using funnel plot and Egger’s regression. Furthermore, we performed Orwin’s Fail-Safe N and cumulative meta-analysis to check for small studies’ effect. Results: Out of 22 studies we included in the qualitative synthesis, 12 studies reported p-values less than 0.05 where smoking significantly favored poor treatment outcomes. The remaining 10 studies reported p-values larger than 0.05 implying that smoking does not affect the treatment outcomes. The meta-analysis found that smoking significantly increased the likelihood of poor tuberculosis treatment outcomes by 51% (OR = 1.51; 95% CI = 1.30 to 1.75 and I-square = 75.1%). In a subgroup analysis, the effect was higher for low- and middle-income countries (OR = 1.74; 95% CI = 1.31 to 2.30) and upper-middle-income economies (OR = 1.52; 95% CI = 1.16 to 1.98) than for high-income ones (OR = 1.34; 95% CI = 1.03 to 1.75). Meta-regression analysis, adjusted for income, found the effect of smoking has not significantly improved over the years (p = 0.92) and thus implying neither of the covariates was the source of the heterogeneity. Egger’s regression test indicated that publication bias is unlikely (p = 0.403). Conclusion: Cigarette smoking is significantly linked with poor tuberculosis treatment outcomes.


  • Open Access

    Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis

    by Abay Burusie, Fikre Enquesilassie, Adamu Addissie, Berhe Dessalegn, Tafesse Lamaro

    Numerous studies have explored an effect of cigarette smoking on tuberculosis treatment outcomes but with dissimilar conclusions. To determine the effect of cigarette smoking on tuberculosis treatment outcomes. PubMed, Cochrane library and Google scholar databases were searched last on February 27, 2019. We applied the random-effects model for the analysis. Publication bias was assessed using funnel plot and Egger’s regression. Furthermore, we performed Orwin’s Fail-Safe N and cumulative meta-analysis to check for small studies’ effect. Out of 22 studies we included in the qualitative synthesis, 12 studies reported p-values less than 0.05 where smoking significantly favored poor treatment outcomes. The remaining 10 studies reported p-values larger than 0.05 implying that smoking does not affect the treatment outcomes. Twenty studies met the criteria for inclusion in a meta-analysis. The meta-analysis found that smoking significantly increased the likelihood of poor tuberculosis treatment outcomes by 51% (OR = 1.51; 95% CI = 1.30 to 1.75 and I-square = 75.1%). In a sub-group analysis, the effect was higher for low- and middle-income countries (OR = 1.74; 95% CI = 1.31 to 2.30) and upper-middle-income economies (OR = 1.52; 95% CI = 1.16 to 1.98) than for high-income ones (OR = 1.34; 95% CI = 1.03 to 1.75) even though the differences in the effects among the strata were not statistically significant as demonstrated by overlapping of confidence intervals of the effects. Meta-regression analysis, adjusted for income economies, found the effect of smoking has not significantly improved over the years (p = 0.92) and thus implying neither of the covariates were source of the heterogeneity. Egger’s regression test indicated that publication bias is unlikely (p = 0.403). Cigarette smoking is significantly linked with poor tuberculosis treatment outcomes.